Fig. 3From: The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-worldPatient journey and access to treatment. Flow diagrams showing, top to bottom: (a) downstream tracking of patients from routine NGS to MTB, and (b) drop-off (and reasons thereof) from MTB accrual to evaluation. Classes of therapeutic agents, access to therapy, and best clinical responses are noted (donut charts, right)Back to article page